Cited by 490Retinal Diseases and TreatmentsDiabetes Management and ResearchAdvanced Glycation End Products research

The DOI matches its Crossref record.

Progression of Incipient Diabetic Retinopathy During Good Glycemic Control

Engerman, Ronald L, Kern, Timothy S·1987·Diabetes

Open this paper in CoChat — free account

Abstract

To assess the extent to which the progression of diabetic retinopathy can be arrested by improved glycemic control, 35 normal dogs were randomly divided into a nondiabetic and three alloxan-induced diabetic groups prospectively identified according to glycemic control: poor control for 5 yr (PC), good control for 5 yr (GC), and poor control for 2.5 yr followed by good control for 2.5 yr (PGC). To achieve good control, insulin was given twice daily together with a measured diet so that hyperglycemia and glucosuria were mild and infrequent, and HbA1 was comparable to normal. Retinal capillary aneurysms and other lesions developed during 60 mo of poor control (group PC) and were inhibited if good control was begun promptly within 2 mo (group GC). In group PGC, retinopathy was absent or equivocal at 2.5 yr of poor control and, surprisingly, was found to develop subsequently despite good glycemic control. Retinopathy in group PGC was greater at autopsy than at 2.5 yr and was greater than in group GC. The results indicate that retinopathy may be preventable but tends to resist arrest even in its incipient stages, before more than the first few aneurysms have appeared.

Integrity signals

Registry

Crossref · 10.2337/diab.36.7.808

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 401–468 of 468

Diabetic Retinopathy
Grosso, A. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-13009-0_17 · Cited by 2
Non-ophthalmologic findings of the diabetes controland complications trial
Saudek, C. D. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(95)80005-0 · Cited by 2
Issues in Management of Diabetic Retinopathy
Ferris, F. L. (1993) · Hospital Practice · doi:10.1080/21548331.1993.11442791 · Cited by 2
Modification of Biochemical Derangements and VEGF Secretion May Prevent Diabetic Retinopathy (DR)
Mondal, L. K., Pramanik, S., De, S. S., Paine, S. K., & Bhaduri, G. (2019) · Journal of Clinical & Experimental Ophthalmology · Cited by 2
Pathogenesis of diabetic microvascular complications
Forbes, J. M., & Harcourt, B. E. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch60 · Cited by 2
Pancreatic transplantation or intensive insulin therapy?
SIEGEL, E. G., & Creutzfeldt, W. (1989) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(89)90039-0 · Cited by 2
Insulin Reversal of Impaired Nitrergic Transmission in the Anococcygeus Muscle from Diabetic Rats
Way, K. J., & Reid, J. J. (1999) · Pharmacology · doi:10.1159/000028311 · Cited by 2
Epigenetics of Diabetic Microvascular Disease
Pirola, L. (2020) · doi:10.1002/9781119309642.ch4 · Cited by 2
Diabetes-induced metabolic disorders of diabetic retinopathy
Li, W., & Zhang, J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-93064-2.00009-3 · Cited by 1
Cellular Abnormalities Induced by High Glucose in Mixed Glial Cultures Are Maintained, Although Glucose Returns to Normal Levels
Solis, B. I. H., Guerrero-Padilla, F., Jiménez, E. M., López, J. M. V., Perea‐Flores, M. D. J., Rodríguez‐Cortés, O., Macías-Pérez, M. E., & Rodríguez, M. H. (2025) · Brain Sciences · doi:10.3390/brainsci15090952 · Cited by 1
“Engerman et al. (1987) first described metabolic memory, showing that the incidence of diabetic retinopathy remained high in diabetic dogs even after 2.5 years of normalized blood glucose [12].”
Influential
Metabolic-inflammatory memory: the common pathological basis and therapeutic targets of metabolic syndrome
何曉碩, 郭战利, & Chen, Q. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10067-0 · Cited by 3
Limitations of Nontransplant Treatment Options for Type 1 Diabetes Mellitus
Kendall, D. M., & Bergenstal, R. M. (2004) · Springer eBooks · doi:10.1007/978-1-4757-4371-5_3 · Cited by 1
Emerging molecular mechanism for cerebral small vessel disease: Lessons from hereditary small vessel disease
Onodera, O., Sekine, Y., Kato, T., Koyama, A., Nozaki, H., & Nishizawa, M. (2014) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.134 · Cited by 1
Roles of Extravasated and Modified Plasma Lipoproteins in Diabetic Retinopathy
Wu, M., & Lyons, T. J. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_15 · Cited by 1
Complications of diabetes: an unsolicited epigenetic memory
Gurusamy, N., Sukumaran, V., Alhazzani, A. A., Shatoor, A. S., Watanabe, K., & Shirai, M. (2015) · Diabesity · doi:10.15562/diabesity.2015.6
Occular manifestation of infectious and noninfestious disease of dogs and cats
Nabi, B., Yousuf, J., Upadhyay, S. R., et al. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18548-9.00019-6 · Cited by 1
Cellular Effects of Elevated Glucose Concentrations and Diabetic Retinopathy
Lorenzi, M., Podestà, F., Mizutani, M., et al. (1998) · KARGER eBooks · doi:10.1159/000060897 · Cited by 1
Diabetes Mellitus y Disfunción Endotelial
Delgado-Butrón, C., Delgado-Torres, C., & Delgado-Torres, L. (2021) · Diagnóstico · doi:10.33734/diagnostico.v59i3.239 · Cited by 1
Role of Lipid, Protein-Derived Toxic Molecules, and Deficiency of Antioxidants behind the Pathogenesis of Diabetic Retinopathy (DR) in Type 2 Diabetes Mellitus
Pramanik, S., Mondal, L. K., Chowdhury, S., Bose, C., Bera, D., & Bhattacharjee, K. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99904 · Cited by 1
Risk factors for retinopathy in type 1 diabetes
Hietala, K. (2013) · Työväentutkimus Vuosikirja · Cited by 1
Comparison of DNA breaks in diabetic dogs and galactosemic dogs developing retinopathy
Kern, T. S., & Engerman, R. L. (1989) · Current Eye Research · doi:10.3109/02713688909000866 · Cited by 1
Self-citation
Retinopathy in Maltese Type 2 Diabetic Patients
Schranz, A., & Zarabinska, L. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb00511.x · Cited by 1
Renal and Retinal Complications in Insulin-Dependent Diabetes Mellitus: The Art of Changing the Outcome
Hoops, S. (1990) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572179001600313 · Cited by 1
The problem of hypoglycaemia — Somogyi or not
Campbell, L. V., & Chisholm, D. J. (1993) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb137975.x · Cited by 1
10.1016/b978-1-4160-2911-3.50034-0
(2000) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50034-0 · Cited by 1
The DCCT and its Implications for Management of Diabetes in Children and Adolescents
White, N. H. (2003) · Springer eBooks · doi:10.1007/978-1-4615-0507-5_16 · Cited by 1
Characterisation of molecular and phenotypic effects induced by Gestational Diabetes Mellitus (GDM) on endothelial cells and placenta tissue
Floris, I. (2014) · UnissResearch (Università degli Studi di Sassari)
Molecular Mechanisms in the Pathogenesis of Diabetic Cardiomyopathy
Chakrabarti, S. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7130-2_27
Diabetes, the Kidney and Retinopathy
Hammes, H. (2012) · Wiley eBooks · doi:10.1002/9781118494073.ch12
Prevalência de valores alternados de hemoglobina glicosilada e lipídios em pacientes com Diabetes Mellitus: Importância do acompanhamento trimestral
Moreira, T. V. O. L., Ruivo, G. F., Rodrigues, E., et al. (2008) · Revista Biociências.
The Role of DNA Methylation in Type 1 and 2 Diabetes as Related to Endothelial Cell Dysfunction
Sarras, M. P. (2015) · MOJ Anatomy & Physiology · doi:10.15406/mojap.2015.01.00005
Le rationnel physiopathologique des risques vasculaires chez les diabétiques
Marre, M., Travert, F., Mohammedi, K., et al. (2009) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(09)71623-2
Capillary Degeneration in Diabetic Retinopathy
Kern, T. S. (2011) · Springer eBooks · doi:10.1007/978-1-60761-150-9_9
Self-citation
Effects of Environmental, Genetic, and Epigenetic Factors on Platelet Glycoproteins and the Development of Diabetic Retinopathy
Petrovič, D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-401717-7.00054-x
Tight metabolic control: The pros and cons
Bibergeil, H. (1990) · Journal of Diabetes and its Complications · doi:10.1016/0891-6632(90)90047-9
Evolution of diabetes: plasticity of epigenetic is a novel key to cause t2dm
Kosta, S., Dangi, C. B. S., Banerjee, N., & Kaur, M. (2013) · International Journal of Bioassays · doi:10.21746/ijbio.2013.12.0013
Effets du contrôle de l’hyperglycémie sur les complications microangiopathiques et neuropathiques (type 1 & type 2)
Moutairou, A., & Roussel, R. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30261-3 · Cited by 1
Clinical management of type 1 diabetes
Iqbal, A., & Heller, S. R. (2015) · doi:10.1002/9781119121725.ch8
VII. Therapy of Diabetes Mellitus Chapter 1. Glycemic Goals
Brillon, D. J. (2004)
A Potential gDNA Methylation Epigenetic Mechanism to Explain the Long Term Complications of Type 1 and 2 Diabetes
Michael Sarras, P. (2016) · MOJ Anatomy & Physiology · doi:10.15406/mojap.2016.02.00049
Diabetic nephropathy—emerging epigenetic
Natarajan, R. D. (2014)
Distribution of Methylated Regions Within gDNA in Acute and Chronic Phases of Diabetes Mellitus
Leontovich, A. A., & Sarras, M. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_76-1
Novologue Therapy Improves Mitochondrial Bioenergetics and Modulates Transcriptome Changes in Diabetic Sensory Neurons
Ma, J. (2015) · KU ScholarWorks (University of Kansas)
The Effects of Metformin on Obesity-Induced Diabetic Retinas
Kim, J. (2017) · OakTrust (Texas A&M University Libraries)
OCULAR FACTORS ASSOCIATED WITH RESISTANCE TO THE DEVELOPMENT OF DIABETIC RETINOPATHY IN TYPE 2 DIABETIC PATIENTS
Sarkar, B., Kumari, E., Dalal, S., et al. (2019) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2019/435
Diabetes Control, Long-Term Complications, and Large Vessel Disease
Nathan, D. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00051-4
Lipid Profile and Electrolyte Imbalance are Associated with Diabetic Retinopathy in Bangladeshi Population
Kabir, M. G., Hossain, D., Mohajan, S., & Rahman, M. (2020) · Asian Journal of Pharmacy Nursing and Medical Sciences · doi:10.24203/ajpnms.v8i3.6206
“Retinopathy in diabetic patients depends on carbohydrate metabolism as well as on other factors like poor diabetes control, dyslipidemia, insulindependent diabetes, hypertension, alcoholism, pregnancy, anemia, hypomagnesemia etc.(5-13).”
Background
The Role of Advanced Glycation in Diabetic Retinopathy
Stitt, A. W. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-563-3_7
“Interestingly, the same memory phenomenon was also shown for retinopathy nearly 20 years previously by Engerman and Kern in variously controlled diabetic dogs ( 46 ).”
Background
Dopamine ameliorates hyperglycemic memory-induced vascular dysfunction in diabetic retinopathyPreprint
Lee, Y., Jeon, H., Lee, A.-J., Kim, M., & Ha, K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.19.476943
Distribution of Methylated Regions Within gDNA in Acute and Chronic Phases of Diabetes Mellitus
Leontovich, A. A., & Sarras, M. P. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_76
The role of inclusion of people with disabilities reflected in the online press
Alexandrescu, M., & Grasu, M. (2022) · Bulletin of Integrative Psychiatry · doi:10.36219/bpi.2022.2.04
“Following this research, other types of animal models have started to emerge (5–8) to several different species of animals, including zebrafish, which is becoming increasingly popular(9).”
Influential
Diabetic Retinopathy
Ashraf, M., Sun, J. K., Silva, P. S., Cavallerano, J. D., & Aiello, L. P. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_15
Roles of Extravasated and Modified Plasma Lipoproteins in Diabetic Retinopathy
Lyons, T. J. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_17
Efecto Legado como Estrategia de Manejo en las Enfermedades Cardiovasculares, Revisión de Tema a Propósito de un Fenómeno Clínico Complejo
León, J. S. T., Ardila, L. J. P., Santamaria, M. J. C., Quintero, V. Q., Campo, E. R. Z., Corzo, M. J. O., Cantillo, F. A. A., Romero, L. D. J., Medina, R. A. A., Solano, M. J. C., et al. (2024) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v8i1.10179
10.1016/s1155-1941(06)44616-3
(2000) · Time to knit · doi:10.1016/s1155-1941(06)44616-3
Research Advances on Hyperglycemia-Induced Metabolic Memory and Non-Coding RNAs
Mei, G., Huan, D., Daoping, R., & Yu, W. (2025) · Global Journal of Obesity Diabetes and Metabolic Syndrome · doi:10.17352/2455-8583.000066
10.1016/b978-1-4160-2911-3.50033-9
(2000) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50033-9
Asociación entre la memoria metabólica y la aparición de complicaciones macrovasculares en pacientes con diabetes mellitus tipo 2. Una revisión del tema
Flores-García, M. A. (2025) · Alad · doi:10.24875/alad.24000002
Parameters of Micro- and Macrocirculation in Young Uncomplicated Type 1 Diabetic Patients—The Role of Metabolic Memory
Neubauer‐Geryk, J., Myśliwiec, M., Zorena, K., & Bieniaszewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010156
Theronostics in Alzheimer's disease and Diabetes
Kashyap, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-40559-4.00002-7
Teratogenicity Involved in Experimental Diabetic Pregnancy
Gäreskog, M. (2006) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Additional file 2 of Simultaneous assessment of stress hyperglycemia ratio and glycemic variability to predict mortality in patients with coronary artery disease: a retrospective cohort study from the MIMIC-IV database
He, H.-M., Zheng, S.-W., Xie, Y.-Y., Wang, Z., Jiao, S.-Q., Yang, F., Li, X.-X., Li, J., & Sun, Y.-H. (2024) · Figshare · doi:10.6084/m9.figshare.25200738
Additional file 3 of Simultaneous assessment of stress hyperglycemia ratio and glycemic variability to predict mortality in patients with coronary artery disease: a retrospective cohort study from the MIMIC-IV database
He, H.-M., Zheng, S.-W., Xie, Y., Wang, Z., Jiao, S.-Q., Yang, F., Li, X.-X., Li, J., & Sun, Y.-H. (2024) · Figshare · doi:10.6084/m9.figshare.26679341
Additional file 1 of Simultaneous assessment of stress hyperglycemia ratio and glycemic variability to predict mortality in patients with coronary artery disease: a retrospective cohort study from the MIMIC-IV database
He, H.-M., Zheng, S.-W., Xie, Y.-Y., Wang, Z., Jiao, S.-Q., Yang, F., Li, X.-X., Li, J., & Sun, Y.-H. (2024) · Figshare · doi:10.6084/m9.figshare.25200647
Additional file 1 of Simultaneous attenuation of hyperglycemic memory-induced retinal, pulmonary, and glomerular dysfunctions by proinsulin C-peptide in diabetes
Jeon, H.-Y., Moon, C.-H., Kim, E.-B., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612315
Computational Evaluation of AMPK‐Activating Phytochemical Analogues Targeting Metabolic Memory in Type 2 Diabetes
Khan, W. A., Farid, A., Chaudhary, M., Preet, G., Rajab, B. S., Alghamdi, S., Abass, K. S., & Gupta, J. (2026) · ChemistrySelect · doi:10.1002/slct.73554
MiRNAs in hyperglycemia-induced metabolic memory: established mechanisms and emerging nuclear activation concepts
Guo, M., Duan, H., Ru, D., Yang, S., & Yu, W. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02187-z
“…levels after 2.5 years of hyperglycemia did not mitigate worsening diabetic retinopathy, whereas intensive glycemic treat-ment effectively inhibited retinal capillary microaneu-rysms and other types of vascular damage when normal blood glucose levels were restored early within two months [24].”
Influential
Association between stress hyperglycemic ratio and all-cause mortality in critically ill patients following cardiac surgery
Yang, Y., Chen, R., Xu, J., et al. (2026) · Medicine · doi:10.1097/md.0000000000050418
“[22] This pathophysiological continuum underscores the critical importance of early glycemic monitoring for SHR management.”

Authors: Engerman, R. L., & Kern, T. S.
Affiliations: University of Wisconsin–Madison (US)
ORCID: Kern, Timothy S
Venue: Diabetes
Publisher: American Diabetes Association
Published: 1987-07-01
Volume: 36
Issue: 7
Pages: 808-812
ISSN: 0012-1797 (ISSN-L)
1939-327X
DOI: 10.2337/diab.36.7.808
OpenAlex: W2104738423
Cited by: 490
References: 0
Citations by year: 2026: 7 · 2025: 10 · 2024: 15 · 2023: 13 · 2022: 12 · 2021: 13 · 2020: 13 · 2019: 16 · 2018: 11 · 2017: 16 · 2016: 14 · 2015: 25 · 2014: 26 · 2013: 22 · 2012: 17
FWCI: 13.21
Type: journal article
Language: en
Open access: closed
Locations: Diabetes (publishedVersion)
PubMed (publishedVersion)
Funders: National Eye Institute (EY00 300)
Topics: Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Keywords: diabetic retinopathy, disease progression, glycemic control, alloxan-induced diabetes, insulin therapy, HbA1c, glycosuria, retinopathy prevention, dogs
MeSH terms: Aneurysm, Animals, Autopsy, Blood Glucose, Capillaries, Diabetic Retinopathy, Dogs, Female, Hyperglycemia, Insulin, Male, Retina

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Progression of Incipient Diabetic Retinopathy During Good Glycemic Control

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks